These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 27391226)

  • 1. GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation.
    Park MJ; Lee SH; Lee SH; Kim EK; Lee EJ; Moon YM; La Cho M
    J Transl Med; 2016 Jul; 14(1):206. PubMed ID: 27391226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRIM19 Impedes Obesity by Regulating Inflammatory White Fat Browning and Promoting Th17/Treg Balance.
    Jhun J; Woo JS; Lee SH; Jeong JH; Jung K; Hur W; Lee SY; Ryu JY; Moon YM; Jung YJ; Song KY; Chang K; Yoon SK; Park SH; Cho ML
    Cells; 2021 Jan; 10(1):. PubMed ID: 33467683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIAS3 suppresses acute graft-versus-host disease by modulating effector T and B cell subsets through inhibition of STAT3 activation.
    Lee SH; Moon SJ; Park MJ; Kim EK; Moon YM; Cho ML
    Immunol Lett; 2014 Jul; 160(1):79-88. PubMed ID: 24718277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 Receptor Blockade Alleviates Graft-versus-Host Disease through Downregulation of an Interleukin-1β-Dependent Glycolytic Pathway in Th17 Cells.
    Park MJ; Lee SH; Lee SH; Lee EJ; Kim EK; Choi JY; Cho ML
    Mediators Inflamm; 2015; 2015():631384. PubMed ID: 26798206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response.
    Betts BC; Sagatys EM; Veerapathran A; Lloyd MC; Beato F; Lawrence HR; Yue B; Kim J; Sebti SM; Anasetti C; Pidala J
    J Leukoc Biol; 2015 Apr; 97(4):807-19. PubMed ID: 25663681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin attenuates acute graft-versus-host disease severity via in vivo regulations on Th1, Th17 and regulatory T cells.
    Park MJ; Moon SJ; Lee SH; Yang EJ; Min JK; Cho SG; Yang CW; Park SH; Kim HY; Cho ML
    PLoS One; 2013; 8(6):e67171. PubMed ID: 23840617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of heme oxygenase-1 in target organs may attenuate acute graft-versus-host disease through regulation of immune balance of TH17/Treg.
    Yu M; Wang J; Fang Q; Liu P; Chen S; Zhe N; Lin X; Zhang Y; Zhao J; Zhou Z
    Transpl Immunol; 2016 Jul; 37():10-17. PubMed ID: 27168057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin attenuates graft-versus-host disease via restricting mammalian target of rapamycin/signal transducer and activator of transcription 3 and promoting adenosine monophosphate-activated protein kinase-autophagy for the balance between T helper 17 and Tregs.
    Park MJ; Lee SY; Moon SJ; Son HJ; Lee SH; Kim EK; Byun JK; Shin DY; Park SH; Yang CW; Cho ML
    Transl Res; 2016 Jul; 173():115-130. PubMed ID: 27126953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-22 aggravates murine acute graft-versus-host disease by expanding effector T cell and reducing regulatory T cell.
    Zhao K; Zhao D; Huang D; Yin L; Chen C; Pan B; Wu Q; Li Z; Yao Y; Shen E; Zeng L; Xu K
    J Interferon Cytokine Res; 2014 Sep; 34(9):707-15. PubMed ID: 24720737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grim19 Attenuates DSS Induced Colitis in an Animal Model.
    Kim JK; Lee SH; Lee SY; Kim EK; Kwon JE; Seo HB; Lee HH; Lee BI; Park SH; Cho ML
    PLoS One; 2016; 11(6):e0155853. PubMed ID: 27258062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-CSF-treated donor CD4+ T cells attenuate acute GVHD through a reduction in Th17 cell differentiation.
    Joo YD; Lee WS; Won HJ; Lee SM; Kim HR; Park JK; Park SG; Choi IW; Choi I; Seo SK
    Cytokine; 2012 Oct; 60(1):277-83. PubMed ID: 22819244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking activator protein 1 activity in donor cells reduces severity of acute graft-versus-host disease through reciprocal regulation of IL-17-producing T cells/regulatory T cells.
    Park MJ; Moon SJ; Lee SH; Kim EK; Yang EJ; Min JK; Park SH; Kim HY; Yang CW; Cho ML
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1112-20. PubMed ID: 24813170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene associated with retinoid-interferon-induced mortality 19 attenuates murine autoimmune arthritis by regulation of th17 and treg cells.
    Moon YM; Lee J; Lee SY; Her YM; Ryu JG; Kim EK; Son HJ; Kwok SK; Ju JH; Yang CW; Park SH; Kim HY; Cho ML
    Arthritis Rheumatol; 2014 Mar; 66(3):569-78. PubMed ID: 24574216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease.
    Iclozan C; Yu Y; Liu C; Liang Y; Yi T; Anasetti C; Yu XZ
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):170-8. PubMed ID: 19804837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytes.
    Janikashvili N; Trad M; Gautheron A; Samson M; Lamarthée B; Bonnefoy F; Lemaire-Ewing S; Ciudad M; Rekhviashvili K; Seaphanh F; Gaugler B; Perruche S; Bateman A; Martin L; Audia S; Saas P; Larmonier N; Bonnotte B
    J Allergy Clin Immunol; 2015 Jun; 135(6):1614-24.e4. PubMed ID: 25630940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cucurbitacin E ameliorates acute graft-versus-host disease by modulating Th17 cell subsets and inhibiting STAT3 activation.
    Kim SY; Park MJ; Kwon JE; Jung KA; Jhun JY; Lee SY; Seo HB; Ryu JY; Beak JA; Choi JY; Cho ML
    Immunol Lett; 2018 Nov; 203():62-69. PubMed ID: 30240636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK2-STAT3 blockade by AG490 suppresses autoimmune arthritis in mice via reciprocal regulation of regulatory T Cells and Th17 cells.
    Park JS; Lee J; Lim MA; Kim EK; Kim SM; Ryu JG; Lee JH; Kwok SK; Park KS; Kim HY; Park SH; Cho ML
    J Immunol; 2014 May; 192(9):4417-24. PubMed ID: 24688026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.